| Home | Lectures | Notes | Images | Flashcards | Case of the Week Archives |
 | Bone | Cardiac | Chest | GI | Miscellaneous | Med Students | Most Common Lists | Quizzes |

 

Return to Case

 

Toxoplasmosis


Ring Enhancing Lesions in a patient with AIDS

Submitted by Marion Brody, MD 

·         Diagnoses to consider in anyone with multiple ring-enhancing lesions:

o       Metastatic disease

o       Demyelinating disease

o       Infection

·         Leading diagnoses in patients with advanced AIDS who have CNS abnormality:

o       Toxoplasma encephalitis (T. Gondii)

o       Primary CNS Lymphoma (EBV)

o       PML (JC)

o       HIV Encephalopathy (HIV)

o       CMV Encephalitis (CMV)

·         Other diagnoses to consider in patients with advanced AIDS who have CNS abnormality:

o       TB (in developing countries)

o       Staphylococcus, Streptococcus, Salmonella, Nocardia,, Rhodococcus, Listeria;

o       Cryptococcus; Histoplasmosis; Candidiasis; Coccidioidomycosis; Aspergillosis; Trypanosomiasis; Herpetic meningoencephalitis; Neurocysticercosis; Meningovascular syphilis; Amebic abscesses

·         How does the physician avoid a brain biopsy?

·         Leading diagnoses in patients with advanced AIDS who have “Mass Lesions”:

o       Toxoplasma encephalitis (T. Gondii)

§         50% of all brain lesions in AIDS patients.

o       Primary CNS Lymphoma (EBV)

§         30% of all brain lesions in AIDS patients

o       (PML, HIV-associated encephalopathy, and CMV encephalitis usually do not cause mass lesions)

·         History

o       Toxo

§         Headache, confusion, +/- fever; focal weakness, seizures; if advanced, dull affect

o       Lymphoma

§         All of above and constitutional symptoms (night sweats, weight loss)

o       PML

§         Rapid neurologic decline (hemiplegia, visual field defects, ataxia, aphasia)

o       HIV Encephalopathy

§         Progressive memory loss, depression, movement disorders

o       CMV encephalitis

§         Confusion, focal deficits

·         Laboratory tests

o       Blood:

§         Anti-toxoplasma IgG antibodies are almost always positive if patient has toxo encephalitis

§         Toxo IgM Abs generally are not detectable in acute infxn; Toxo IgG quantitative levels do not reflect disease activity.

§         Patients with toxo usually  have CD4 < 100

§         Patients with CMV encephalitis usually have CD4< 50

o       A  lumbar puncture is contraindicated if patient has lesions producing mass-effect and has focal signs

o       CSF:

§         Toxo, PCNSL, and PML shows <500 lymphs/uL, increased protein, normal glucose.

§         Lymphoma may or may not show abnormal lymphocytes

o       Toxo PCR  is 50% sensitive, up to 100% specific.

o       EBV PCR sensitivity/specificity varies with testing center

o       JC virus PCR is up to 93% sensitive and specific

o       CMV PCR  is 80% sensitive, 90% specific

·         Imaging on CT and MRI

o       Toxoplasma Encephalitis       

§         Thin-walled ring-enhancing lesions, surrounding edema; rarely diffuse encephalitis

§         Multiple lesions 80%

§         Usually hyperintense with hypointense rim on T2 (can have decreased signal in central areas from calcium and hemorrhage)

§         Basal Ganglia, G/W junction; parietal, frontal, thalamus

§         More likely to appear in posterior fossa than PCNSL

§         < 4 cm

 

T1 weighted, gadolinium-enhanced sagittal MRI images of the brain demonstrate two
ring-enhancing lesions, one (red arrows) in the thalamus and the other (yellow arrow)
in the cerebellum.
For a version of this photo without the arrows, click here

 

 

 

o       Primary CNS Lymphoma

§         Ring-enhancing lesions, surrounding edema

§         Multiple lesions 50%

§         Variable signal on T2; isointense or hypointense on T1

§         Basal Ganglia, deep white matter

§         More likely to cross corpus callosum or occur in periependymal areas than TE

§         Can be > 4cm

o       PML:

·         Multiple areas of demyelination, without contrast-enhancement or edema

·         Bilateral, asymmetric; hypointense on T1, hyperintense on T2

·         Can see atypical enhancing lesions with immune reconstitution syndrome

·         Periventricular and subcortical white matter (rarely grey matter)

o       HIV Encephalitis:

§         Indistinct lesions in subcortical white matter

§         Symmetric; hyperintense on T2

o       CMV Encephalitis:

§         Scattered micronodules in the cortex, BG, brain stem, and cerebellum; or

§         Large ventricles with periventricular enhancement/hyperintensity on T2; or

§         Ring-enhancing lesions with edema

·         Other imaging modalities:

o       SPECT – lymphoma greater thallium uptake than Toxo

o       PET – lymphoma greater glucose + methionine uptake than Toxo

o       Perfusion MRI – Increased flow in lymphoma, decreased in Toxo

o       MR Spectroscopy – TBA

·         Take home points

o       90% likelihood it’s Toxo if all of the following criteria are met:

§         Toxo IgG (+) in serum.

§         Patient with a CD4 < 100 is not receiving prophylaxis for Toxo

§         Multiple ring enhancing lesions on CT or MRI

o       In these cases, often patient is treated presumptively for Toxo

o       If it’s Toxo, should see clinical improvement in 1 week (caveat: steroids can improve immediate symptoms by reducing brain edema without any true reduction in severity of infection)

o       If it’s Toxo, should see radiographic improvement within 2 weeks 

 

Chepuri, NB. Ring Enhancing Cerebral Lesions. In Magnetic Resonance Imaging of CNS Disease, York DH (Ed.), 2002. Mosby, Philadelphia, PA.

Heller, HM. Toxoplasmosis in HIV-infected patients. In: Up To Date, April 23, 2005, Aronson, MD, Fletcher, RH, Fletcher, HW, Rind, DM (Eds.) Waltham, MA.

Koralnik, IJApproach to HIV-infected patients with central nervous system lesions. In: Up To Date, March 30, 2005, Aronson, MD, Fletcher, RH, Fletcher, HW, Rind, DM (Eds.) Waltham, MA.